Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 307


Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series.

Patel MP, Kirkpatrick JP, Johnson MO, Healy P, Herndon JE 2nd, Lipp ES, Miller ES, Desjardins A, Randazzo D, Friedman HS, Ashley DM, Peters KB.

J Neurooncol. 2020 Mar 5. doi: 10.1007/s11060-020-03446-3. [Epub ahead of print]


Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma.

Wick A, Desjardins A, Suarez C, Forsyth P, Gueorguieva I, Burkholder T, Cleverly AL, Estrem ST, Wang S, Lahn MM, Guba SC, Capper D, Rodon J.

Invest New Drugs. 2020 Mar 5. doi: 10.1007/s10637-020-00910-9. [Epub ahead of print]


Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial.

Reardon DA, Desjardins A, Vredenburgh JJ, O'Rourke DM, Tran DD, Fink KL, Nabors LB, Li G, Bota DA, Lukas RV, Ashby LS, Duic JP, Mrugala MM, Cruickshank S, Vitale L, He Y, Green JA, Yellin MJ, Turner CD, Keler T, Davis TA, Sampson JH; ReACT trial investigators.

Clin Cancer Res. 2020 Feb 7. doi: 10.1158/1078-0432.CCR-18-1140. [Epub ahead of print]


New developments in optical sensing technology: an interview with Adrien Desjardins.

Desjardins A.

Future Cardiol. 2020 Mar;16(2):65-67. doi: 10.2217/fca-2019-0085. Epub 2020 Jan 10.


Use of a flexible optical fibre bundle to interrogate a Fabry-Perot sensor for photoacoustic imaging.

Ansari R, Zhang EZ, Desjardins AE, David AL, Beard PC.

Opt Express. 2019 Dec 23;27(26):37886-37899. doi: 10.1364/OE.27.037886.


Minimally invasive photoacoustic imaging: Current status and future perspectives.

Zhao T, Desjardins AE, Ourselin S, Vercauteren T, Xia W.

Photoacoustics. 2019 Oct 31;16:100146. doi: 10.1016/j.pacs.2019.100146. eCollection 2019 Dec. Review.


Interventional photoacoustics: using light to sound out the path to safe, effective interventions.

van Soest G, Desjardins A.

Phys Med Biol. 2019 Nov 15;64(22):220401. doi: 10.1088/1361-6560/ab50d8. No abstract available.


The role of chemotherapy in the treatment of central neurocytoma.

Johnson MO, Kirkpatrick JP, Patel MP, Desjardins A, Randazzo DM, Friedman HS, Ashley DM, Peters KB.

CNS Oncol. 2019 Nov 1;8(3):CNS41. doi: 10.2217/cns-2019-0012. Epub 2019 Nov 5.


Photoacoustic imaging of the human placental vasculature.

Maneas E, Aughwane R, Huynh N, Xia W, Ansari R, Kuniyil Ajith Singh M, Hutchinson JC, Sebire NJ, Arthurs OJ, Deprest J, Ourselin S, Beard PC, Melbourne A, Vercauteren T, David AL, Desjardins AE.

J Biophotonics. 2019 Oct 29:e201900167. doi: 10.1002/jbio.201900167. [Epub ahead of print]


Source Density Apodization: Image Artifact Suppression Through Source Pitch Nonuniformity.

Alles EJ, Desjardins AE.

IEEE Trans Ultrason Ferroelectr Freq Control. 2020 Mar;67(3):497-504. doi: 10.1109/TUFFC.2019.2945636. Epub 2019 Oct 4.


Second primary cancers in long-term survivors of glioblastoma.

Kim JY, Jackman JG, Woodring S, McSherry F, Herndon JE, Desjardins A, Friedman HS, Peters KB.

Neurooncol Pract. 2019 Sep;6(5):386-391. doi: 10.1093/nop/npz001. Epub 2019 Feb 4.


Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide.

Patel MP, Woodring S, Randazzo DM, Friedman HS, Desjardins A, Healy P, Herndon JE 2nd, McSherry F, Lipp ES, Miller E, Peters KB, Affronti ML.

Support Care Cancer. 2020 May;28(5):2229-2238. doi: 10.1007/s00520-019-05039-x. Epub 2019 Aug 22.


Complementary and integrative health interventions and their association with health-related quality of life in the primary brain tumor population.

Randazzo DM, McSherry F, Herndon JE, Affronti ML, Lipp ES, Flahiff C, Miller E, Woodring S, Boulton S, Desjardins A, Ashley DM, Friedman HS, Peters KB.

Complement Ther Clin Pract. 2019 Aug;36:43-48. doi: 10.1016/j.ctcp.2019.05.002. Epub 2019 May 18.


Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations.

Chandramohan V, Bao X, Yu X, Parker S, McDowall C, Yu YR, Healy P, Desjardins A, Gunn MD, Gromeier M, Nair SK, Pastan IH, Bigner DD.

J Immunother Cancer. 2019 May 29;7(1):142. doi: 10.1186/s40425-019-0614-0.


Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice.

Desjardins A, Herndon JE 2nd, McSherry F, Ravelo A, Lipp ES, Healy P, Peters KB, Sampson JH, Randazzo D, Sommer N, Friedman AH, Friedman HS.

Health Sci Rep. 2019 Feb 13;2(4):e114. doi: 10.1002/hsr2.114. eCollection 2019 Apr.


Computational fluid dynamics with imaging of cleared tissue and of in vivo perfusion predicts drug uptake and treatment responses in tumours.

d'Esposito A, Sweeney PW, Ali M, Saleh M, Ramasawmy R, Roberts TA, Agliardi G, Desjardins A, Lythgoe MF, Pedley RB, Shipley R, Walker-Samuel S.

Nat Biomed Eng. 2018 Oct;2(10):773-787. doi: 10.1038/s41551-018-0306-y. Epub 2018 Oct 10.


A directional fibre optic ultrasound transmitter based on a reduced graphene oxide and polydimethylsiloxane composite.

Colchester RJ, Alles EJ, Desjardins AE.

Appl Phys Lett. 2019 Mar 18;114(11):113505. doi: 10.1063/1.5089750. Epub 2019 Mar 21.


All-Optical Rotational Ultrasound Imaging.

Colchester RJ, Little C, Dwyer G, Noimark S, Alles EJ, Zhang EZ, Loder CD, Parkin IP, Papakonstantinou I, Beard PC, Finlay MC, Rakhit RD, Desjardins AE.

Sci Rep. 2019 Apr 3;9(1):5576. doi: 10.1038/s41598-019-41970-z.


Magnetic resonance angiography imaging of pulmonary embolism using agents with blood pool properties as an alternative to computed tomography to avoid radiation exposure.

Pressacco J, Papas K, Lambert J, Paul Finn J, Chauny JM, Desjardins A, Irislimane Y, Toporowicz K, Lanthier C, Samson P, Desnoyers M, Maki JH.

Eur J Radiol. 2019 Apr;113:165-173. doi: 10.1016/j.ejrad.2019.02.007. Epub 2019 Feb 11.


Family medicine physician teachers and residents' intentions to prescribe and interpret spirometry: a descriptive cross-sectional study.

Desjardins A, Boulay MÈ, Gagné M, Simon M, Boulet LP.

J Asthma. 2020 Feb;57(2):149-159. doi: 10.1080/02770903.2018.1553052. Epub 2019 Mar 23.


Dynamic physiological temperature and pressure sensing with phase-resolved low-coherence interferometry.

Coote JM, Alles EJ, Noimark S, Mosse CA, Little CD, Loder CD, David AL, Rakhit RD, Finlay MC, Desjardins AE.

Opt Express. 2019 Feb 18;27(4):5641-5654. doi: 10.1364/OE.27.005641.


Haptic Guidance Based on All-Optical Ultrasound Distance Sensing for Safer Minimally Invasive Fetal Surgery.

Gruijthuijsen C, Colchester R, Devreker A, Javaux A, Maneas E, Noimark S, Xia W, Stoyanov D, Reynaerts D, Deprest J, Ourselin S, Desjardins A, Vercauteren T, Vander Poorten E.

J Med Robot Res. 2018 Apr 20;3. doi: 10.1142/S2424905X18410015.


Micron resolution, high-fidelity three-dimensional vascular optical imaging phantoms.

Little CD, Poduval RK, Caulfield R, Noimark S, Colchester RJ, Loder CD, Tiwari MK, Rakhit RD, Papakonstantinou I, Desjardins AE.

J Biomed Opt. 2019 Feb;24(2):1-4. doi: 10.1117/1.JBO.24.2.020502.


Placenta Imaging Workshop 2018 report: Multiscale and multimodal approaches.

Slator P, Aughwane R, Cade G, Taylor D, David AL, Lewis R, Jauniaux E, Desjardins A, Salomon LJ, Millischer AE, Tsatsaris V, Rutherford M, Johnstone ED, Melbourne A; participants of the workshop.

Placenta. 2019 Apr;79:78-82. doi: 10.1016/j.placenta.2018.10.010. Epub 2018 Oct 31. Review.


Adjunctive perampanel for glioma-associated epilepsy.

Dunn-Pirio AM, Woodring S, Lipp E, Herndon JE 2nd, Healy P, Weant M, Randazzo D, Desjardins A, Friedman HS, Peters KB.

Epilepsy Behav Case Rep. 2018 Oct 9;10:114-117. doi: 10.1016/j.ebcr.2018.09.003. eCollection 2018.


Video-rate all-optical ultrasound imaging.

Alles EJ, Noimark S, Maneas E, Zhang EZ, Parkin IP, Beard PC, Desjardins AE.

Biomed Opt Express. 2018 Jul 2;9(8):3481-3494. doi: 10.1364/BOE.9.003481. eCollection 2018 Aug 1.


All-optical forward-viewing photoacoustic probe for high-resolution 3D endoscopy.

Ansari R, Zhang EZ, Desjardins AE, Beard PC.

Light Sci Appl. 2018 Oct 10;7:75. doi: 10.1038/s41377-018-0070-5. eCollection 2018.


Three-Dimensional Ultrasonic Needle Tip Tracking with a Fiber-Optic Ultrasound Receiver.

Xia W, West SJ, Finlay MC, Pratt R, Mathews S, Mari JM, Ourselin S, David AL, Desjardins AE.

J Vis Exp. 2018 Aug 21;(138). doi: 10.3791/57207.


Through-needle all-optical ultrasound imaging in vivo: a preclinical swine study.

Finlay MC, Mosse CA, Colchester RJ, Noimark S, Zhang EZ, Ourselin S, Beard PC, Schilling RJ, Parkin IP, Papakonstantinou I, Desjardins AE.

Light Sci Appl. 2017 Dec 1;6(12):e17103. doi: 10.1038/lsa.2017.103. eCollection 2017 Dec.


All-optical dual photoacoustic and optical coherence tomography intravascular probe.

Mathews SJ, Little C, Loder CD, Rakhit RD, Xia W, Zhang EZ, Beard PC, Finlay MC, Desjardins AE.

Photoacoustics. 2018 Jul 24;11:65-70. doi: 10.1016/j.pacs.2018.07.002. eCollection 2018 Sep.


Recurrent Glioblastoma Treated with Recombinant Poliovirus.

Desjardins A, Gromeier M, Herndon JE 2nd, Beaubier N, Bolognesi DP, Friedman AH, Friedman HS, McSherry F, Muscat AM, Nair S, Peters KB, Randazzo D, Sampson JH, Vlahovic G, Harrison WT, McLendon RE, Ashley D, Bigner DD.

N Engl J Med. 2018 Jul 12;379(2):150-161. doi: 10.1056/NEJMoa1716435. Epub 2018 Jun 26.


Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma.

Affronti ML, Jackman JG, McSherry F, Herndon JE 2nd, Massey EC Jr, Lipp E, Desjardins A, Friedman HS, Vlahovic G, Vredenburgh J, Peters KB.

Oncologist. 2018 Aug;23(8):889-e98. doi: 10.1634/theoncologist.2018-0149. Epub 2018 Apr 17.


Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma.

Ellingson BM, Aftab DT, Schwab GM, Hessel C, Harris RJ, Woodworth DC, Leu K, Chakhoyan A, Raymond C, Drappatz J, de Groot J, Prados MD, Reardon DA, Schiff D, Chamberlain M, Mikkelsen T, Desjardins A, Holland J, Ping J, Weitzman R, Wen PY, Cloughesy TF.

Neuro Oncol. 2018 Sep 3;20(10):1411-1418. doi: 10.1093/neuonc/noy054.


Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models.

Keir ST, Chandramohan V, Hemphill CD, Grandal MM, Melander MC, Pedersen MW, Horak ID, Kragh M, Desjardins A, Friedman HS, Bigner DD.

J Neurooncol. 2018 Jul;138(3):489-498. doi: 10.1007/s11060-018-2832-6. Epub 2018 Mar 21.


Gel wax-based tissue-mimicking phantoms for multispectral photoacoustic imaging.

Maneas E, Xia W, Ogunlade O, Fonseca M, Nikitichev DI, David AL, West SJ, Ourselin S, Hebden JC, Vercauteren T, Desjardins AE.

Biomed Opt Express. 2018 Feb 15;9(3):1151-1163. doi: 10.1364/BOE.9.001151. eCollection 2018 Mar 1.


Soutenir le déploiement de la prescription infirmière dans les milieux cliniques.

Brault I, Desjardins AA, Borgès Da Silva R, Dubois CA, Motulsky A, Prud'homme A.

Perspect Infirm. 2018 Jan-Feb;15(1):46-50. French. No abstract available.


Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas.

Peters KB, Lipp ES, Miller E, Herndon JE 2nd, McSherry F, Desjardins A, Reardon DA, Friedman HS.

J Neurooncol. 2018 Apr;137(2):349-356. doi: 10.1007/s11060-017-2724-1. Epub 2017 Dec 21.


Anatomically realistic ultrasound phantoms using gel wax with 3D printed moulds.

Maneas E, Xia W, Nikitichev DI, Daher B, Manimaran M, Wong RYJ, Chang CW, Rahmani B, Capelli C, Schievano S, Burriesci G, Ourselin S, David AL, Finlay MC, West SJ, Vercauteren T, Desjardins AE.

Phys Med Biol. 2018 Jan 5;63(1):015033. doi: 10.1088/1361-6560/aa9e2c.


Wide-field spectrally resolved quantitative fluorescence imaging system: toward neurosurgical guidance in glioma resection.

Xie Y, Thom M, Ebner M, Wykes V, Desjardins A, Miserocchi A, Ourselin S, McEvoy AW, Vercauteren T.

J Biomed Opt. 2017 Nov;22(11):1-14. doi: 10.1117/1.JBO.22.11.116006.


Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma.

Ghiaseddin A, Reardon D, Massey W, Mannerino A, Lipp ES, Herndon JE 2nd, McSherry F, Desjardins A, Randazzo D, Friedman HS, Peters KB.

Oncologist. 2018 Feb;23(2):157-e21. doi: 10.1634/theoncologist.2017-0501. Epub 2017 Nov 13.


Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.

Reap EA, Suryadevara CM, Batich KA, Sanchez-Perez L, Archer GE, Schmittling RJ, Norberg PK, Herndon JE 2nd, Healy P, Congdon KL, Gedeon PC, Campbell OC, Swartz AM, Riccione KA, Yi JS, Hossain-Ibrahim MK, Saraswathula A, Nair SK, Dunn-Pirio AM, Broome TM, Weinhold KJ, Desjardins A, Vlahovic G, McLendon RE, Friedman AH, Friedman HS, Bigner DD, Fecci PE, Mitchell DA, Sampson JH.

Cancer Res. 2018 Jan 1;78(1):256-264. doi: 10.1158/0008-5472.CAN-17-0469. Epub 2017 Nov 1.


Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy.

Cloughesy TF, Drappatz J, de Groot J, Prados MD, Reardon DA, Schiff D, Chamberlain M, Mikkelsen T, Desjardins A, Ping J, Holland J, Weitzman R, Wen PY.

Neuro Oncol. 2018 Jan 22;20(2):259-267. doi: 10.1093/neuonc/nox151.


Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy.

Wen PY, Drappatz J, de Groot J, Prados MD, Reardon DA, Schiff D, Chamberlain M, Mikkelsen T, Desjardins A, Holland J, Ping J, Weitzman R, Cloughesy TF.

Neuro Oncol. 2018 Jan 22;20(2):249-258. doi: 10.1093/neuonc/nox154.


Ultrasonic Needle Tracking with a Fibre-Optic Ultrasound Transmitter for Guidance of Minimally Invasive Fetal Surgery.

Xia W, Noimark S, Ourselin S, West SJ, Finlay MC, David AL, Desjardins AE.

Med Image Comput Comput Assist Interv. 2017 Sep;10434:637-645. doi: 10.1007/978-3-319-66185-8_72. Epub 2017 Sep 4.


A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population.

Randazzo DM, McSherry F, Herndon JE 2nd, Affronti ML, Lipp ES, Flahiff C, Miller E, Woodring S, Freeman M, Healy P, Minchew J, Boulton S, Desjardins A, Vlahovic G, Friedman HS, Keir S, Peters KB.

J Neurooncol. 2017 Sep;134(2):363-369. doi: 10.1007/s11060-017-2535-4. Epub 2017 Jul 1.


Optical fiber ultrasound transmitter with electrospun carbon nanotube-polymer composite.

Poduval RK, Noimark S, Colchester RJ, Macdonald TJ, Parkin IP, Desjardins AE, Papakonstantinou I.

Appl Phys Lett. 2017 May 29;110(22):223701. doi: 10.1063/1.4984838. Epub 2017 Jun 1.


Looking beyond the imaging plane: 3D needle tracking with a linear array ultrasound probe.

Xia W, West SJ, Finlay MC, Mari JM, Ourselin S, David AL, Desjardins AE.

Sci Rep. 2017 Jun 16;7(1):3674. doi: 10.1038/s41598-017-03886-4.


Tau secretion is correlated to an increase of Golgi dynamics.

Mohamed NV, Desjardins A, Leclerc N.

PLoS One. 2017 May 26;12(5):e0178288. doi: 10.1371/journal.pone.0178288. eCollection 2017.


A reconfigurable all-optical ultrasound transducer array for 3D endoscopic imaging.

Alles EJ, Fook Sheung N, Noimark S, Zhang EZ, Beard PC, Desjardins AE.

Sci Rep. 2017 Apr 26;7(1):1208. doi: 10.1038/s41598-017-01375-2.


Rab7A regulates tau secretion.

Rodriguez L, Mohamed NV, Desjardins A, Lippé R, Fon EA, Leclerc N.

J Neurochem. 2017 May;141(4):592-605. doi: 10.1111/jnc.13994. Epub 2017 Mar 29.

Supplemental Content

Loading ...
Support Center